Therapeutic education program for patients with chronic inflammatory diseases on biotherapy
Official title: Impact of the Therapeutic Education Program "living with Chronic Inflammatory Disease Under Biotherapy" on Compliance and Quality of Life of Patients
Run by Groupe Hospitalier de Bretagne Sud · NCT06620770 · Data updated 2026-11-12
This study tests a new education program for patients with chronic inflammatory diseases on biotherapy to see if it helps them understand their treatment better and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 126 (estimated) |
| Sponsor | Groupe Hospitalier de Bretagne Sud Academic / other |
| Locations | 1 site (Lorient) |
| Status | Recruiting |
| Started | February 14, 2025 |
| Main results expected | March 2027 |
| Study ends | March 2028 |
| Registry record updated | March 14, 2025 |
| Trial ID | NCT06620770 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with chronic inflammatory diseases being treated with subcutaneous biotherapy at the Groupe Hospitalier de Bretagne Sud.
✕Probably not a fit
Patients who are cognitively impaired or unable to participate in the program due to legal or health restrictions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the impact of a therapeutic education program designed for patients with chronic inflammatory diseases who are receiving subcutaneous biotherapy. The program aims to enhance patient knowledge, adherence to treatment, and overall quality of life. Participants will complete the Morisky scale and SF 12 quality of life questionnaire at various intervals over 18 months to assess the program's effectiveness. Patients who choose not to participate will be included in a control group for comparison.
Why it matters
Potential benefit: If successful, this program could significantly improve treatment adherence and quality of life for patients with chronic inflammatory diseases.
How similar studies have gone: Previous studies have shown that therapeutic education programs can effectively improve patient knowledge and adherence, suggesting a positive outlook for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All major patients followed up on GHBS for chronic inflammatory disease treated with S/C biotherapy. * Patients not opposed to their participation in the research. * Less than 3 months between inclusion and start of Therapeutic Education Program. Exclusion Criteria: * Subcutaneous injection by another person. * Patients with cognitive impairment. * Persons of legal age who are the subject of a legal protection (safeguarding of justice, curatorship, guardianship), persons deprived of liberty. * Pregnant women. * Persons not covered by social security.
Where it's running
-
Groupe Hospitalier de Bretagne Sud
Lorient, France Recruiting
Study contacts
- Principal investigator: Olivier Gall — Groupe Hospitalier de Bretagne Sud
- Study coordinator: Olivier Gall
- Email: o.gall@ghbs.bzh
- Phone: 02 97 06 79 11
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Creating a database for patients with immune-mediated inflammatory diseases
This study is creating a database and biobank for patients with immune-related diseases to see if new information can help improve treatments and understand their conditions better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.